Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 14.30 USD | -3.25% |
|
-7.74% | -8.80% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.5 | +99.3% | 6 | ||||||
| 681.13 | +15.02% | 23 | ||||||
| 223.24 | +6.58% | 21 | ||||||
| 275.17 | +5.91% | 18 | ||||||
| 433.02 | +15.63% | 27 | ||||||
| 266,031.64 | +38.34% | 23 | ||||||
| 581.83 | -6.27% | 12 | ||||||
| 268.37 | +23.52% | 19 | ||||||
| 72.53 | -0.43% | 14 | ||||||
| 281 | -4.81% | 14 | ||||||
| 185.56 | +7.74% | 16 | ||||||
| 63.36 | -12.84% | 14 | ||||||
| 47.08 | -1.87% | 11 | ||||||
| 70.73 | -2.2% | 11 | ||||||
| 138.97 | +36.51% | 6 | ||||||
| 638.68 | +69.89% | 19 | ||||||
| 134.85 | +0.07% | 11 | ||||||
| 170.38 | +10.41% | 13 | ||||||
| 130.91 | +9.27% | 22 | ||||||
| 88 | +47.3% | 22 | ||||||
| Average | 13,527.25 | +17.85% | 16 | ||||||
| Weighted average by Cap. | 22,043.57 | +13.44% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
